|Articles|March 10, 2022
Survey: Pandemic impact on consumer trust in biopharma
Author(s)Reverba
The biopharma industry launched COVID vaccines and treatments in record time. How did this impact consumer trust? We asked, and compared survey results with 2017 data.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Trending on PharmExec
1
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
2
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
3
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
4
FDA Announces New Biosimilar-Targeted Draft Guidance
5
